Federal contracts
$3.9BHealthcarePaper Trail research
Cencora
A pharmaceutical distribution company serving healthcare providers across the United States.
At a Glance
Highlights from available records. Missing information does not mean an activity did not occur.
Tracked federal obligations
$3.9B
2025-09-23–2026-09-22. Commitments to spend, not cash paid.
Inspect records →Largest tracked awarding agency
Department of Defense
2025-09-23–2026-09-22 · $3.9B · 100.0% of tracked obligations
Inspect records →In-house lobbying expenses
$1.7M
2026 YTD · latest filings; in-house expenses and outside-firm income are not combined.
Inspect records →Documented people connections
37
Distinct people with published, verified positions in the records shown below.
Inspect records →Industry
Healthcare
Organization classification recorded by Paper Trail.
Inspect records →Federal spending
Total federal obligations
$3.9B
Obligations recorded from September 23, 2025 through September 22, 2026. Obligations are promises by the federal government to spend money, not necessarily cash already paid.
As of
September 22, 2026
Paper Trail overview
About This Organization
A pharmaceutical distribution company serving healthcare providers across the United States.
Editorial context
Why It Is Included
Included because this organization appears in federal spending records and is part of The Paper Trail Project's public-interest research directory.
Paper Trail research
Why you may have heard of it
Formerly AmerisourceBergen and one of the nation's largest drug distributors.
Direct public money received
Public Money Profile
Federal obligations are shown by award type and kept separate from tax incentives or workforce public-benefit research. These categories should not be added into a generic “subsidy” figure.
Federal grants
$0Direct payments
$0Federal loans
$0Other assistance
$0No published source-backed estimate linked unless shown elsewhere on this profile.
Not included without attributable official records.
Connection explorer
Follow the Full Trail
Move from this organization to federal agencies, spending categories, reviewed corporate relationships, lobbying disclosures, its affiliated PAC, and political recipients.
Open Connection Explorer →Sourced institutional roles
Leadership & People
Lobbying Connections
ADAM STEINMETZ
Registered lobbyist
View sourced career record →DARRELL ROGERSRegistered lobbyist
View sourced career record →DOUGLAS S WILEYRegistered lobbyist
View sourced career record →THOMAS WHARTONRegistered lobbyist
View sourced career record →JASON R. MONEYRegistered lobbyist
View sourced career record →DEEMA TARAZIRegistered lobbyist
View sourced career record →COREY AUSTIN MCGEERegistered lobbyist
View sourced career record →KYLE NEVINSRegistered lobbyist
View sourced career record →JONATHAN SLEMRODRegistered lobbyist
View sourced career record →STEVE STOMBRESRegistered lobbyist
View sourced career record →BRIAN THOMAS MCGUIRERegistered lobbyist
View sourced career record →SHELLY MUI-LIPNIKRegistered lobbyist
View sourced career record →JOEL WHITERegistered lobbyist
View sourced career record →JONATHAN TOWERSRegistered lobbyist
View sourced career record →WILLIAM DUNHAMRegistered lobbyist
View sourced career record →BENJAMIN R HOWARDRegistered lobbyist
View sourced career record →LAUREN ALEXANDRA MISHRegistered lobbyist
View sourced career record →PARKER H. POLINGRegistered lobbyist
View sourced career record →JOHN HOLSCLAWRegistered lobbyist
View sourced career record →BRADFORD TALLAMYRegistered lobbyist
View sourced career record →ANDREW USYKRegistered lobbyist
View sourced career record →FREDERICK ESSISRegistered lobbyist
View sourced career record →GREGORY SUNSTRUMRegistered lobbyist
View sourced career record →JOHN LEGANSKIRegistered lobbyist
View sourced career record →ALICE LUGORegistered lobbyist
View sourced career record →JOHN J O'NEILL jrRegistered lobbyist
View sourced career record →RITA E NORTONRegistered lobbyist
View sourced career record →ZACHARY PFISTERRegistered lobbyist
View sourced career record →MICHAEL TONGOURRegistered lobbyist
View sourced career record →DAVID J SCHIAPPARegistered lobbyist
View sourced career record →MANNY ROSSMANRegistered lobbyist
View sourced career record →KATHERINE WINKLER KEATINGRegistered lobbyist
View sourced career record →COLTON HENNINGRegistered lobbyist
View sourced career record →ELIZABETH KELLEYRegistered lobbyist
View sourced career record →EMILY FELDERRegistered lobbyist
View sourced career record →VIVIENNE STAFFORD MITCHELLRegistered lobbyist
View sourced career record →ASHLEY ROSE O'SULLIVANRegistered lobbyist
View sourced career record →Federal data
Spending Over Time
Prime-award transaction obligations attributed to this USAspending recipient. Negative totals can reflect deobligations or corrections.
$2.2BFY2017
$2.3BFY2018
$2.4BFY2019
$2.2BFY2020
$2.1BFY2021
$1.6BFY2022
$2.1BFY2023
$1.7BFY2024
$103KFY2025
$3.9BFY2026To date
The current fiscal year is partial and will change as USAspending publishes additional transactions.
Federal data
Who funds Cencora?
The federal agencies and offices responsible for the organization’s recorded obligations.
1Department of Defense$3,947,835,392100.0% of total2Department of Veterans Affairs$1,529,7480.0% of total3Department of Justice$204,8550.0% of total
ConnectedLast refreshed September 22, 2026
Prime-award transaction obligations from 2025-09-23 through 2026-09-22, grouped by top-tier awarding agency.
Federal data
What Federal Agencies Bought or Funded From Cencora
USAspending classifies federal obligations using product and service codes for contracts and assistance-listing categories for grants and other assistance. These records describe federal awards to the organization—not the organization’s own operating expenses.
Products and services
DRUGS AND BIOLOGICALS
PSC 6505
$3,905,314,02098.9% of total
MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
PSC 6515
$44,255,9751.1% of total
Prime-award transaction obligations from 2025-09-23 through 2026-09-22. Categories can be broad and reflect federal coding, not Paper Trail editorial conclusions. View USAspending source ↗
Corporate structure
What does Cencora control?
Business segments, subsidiaries, joint ventures, and acquired companies connected to the parent organization.
Legal-subsidiary lists are drawn from reviewed SEC Exhibit 21 filings. Companies may omit subsidiaries that are not considered significant under SEC reporting rules, so these lists are not necessarily exhaustive.
Legal subsidiaries21
AB Singapore Investments Pte. Ltd
Singapore
SEC filing source ↗AH UK Holdco 1 Limited
UK
SEC filing source ↗Amerisource Receivables Financial Corporation
Delaware
SEC filing source ↗AmerisourceBergen Drug Corporation
Delaware
SEC filing source ↗AmerisourceBergen Global Holdings GmbH
Switzerland
SEC filing source ↗AmerisourceBergen Global Manufacturer Services GmbH
Switzerland
SEC filing source ↗AmerisourceBergen Group GmbH
Switzerland
SEC filing source ↗AmerisourceBergen International B.V
Netherlands
SEC filing source ↗AmerisourceBergen International Holdings LLC
Delaware
SEC filing source ↗AmerisourceBergen Luxembourg S.a.r.L
Luxembourg
SEC filing source ↗AmerisourceBergen Services Corporation
Delaware
SEC filing source ↗AmerisourceBergen Sourcing, LLC
Delaware
SEC filing source ↗AmerisourceBergen Specialty Group, LLC
Delaware
SEC filing source ↗AmerisourceBergen UK Holdings Ltd
UK
SEC filing source ↗ASD Specialty Healthcare, LLC
California
SEC filing source ↗BPL Group, LLC
Delaware
SEC filing source ↗Cencora Global Procurement Limited
Ireland
SEC filing source ↗Cencora International Financing Holdings LLC
Delaware
SEC filing source ↗Cencora International Holdings Inc
Delaware
SEC filing source ↗International Physician Networks, L.L.C
Delaware
SEC filing source ↗World Courier Group S.à r.l
Luxembourg
SEC filing source ↗Acquisitions5
Alliance HealthcareSEC filing source ↗
majority of Walgreens Boots AllianceSEC filing source ↗
OneOncologySEC filing source ↗
PharmaLexSEC filing source ↗
Federal disclosures
Federal Lobbying
In-house lobbying expenses · 2026 YTD
$1.7M
Expenses reported on filings where the organization registers and lobbies on its own behalf.
Outside lobbying-firm income · 2026 YTD
$570K
Income reported by outside registrants for work on behalf of this client.
These categories are shown separately and are not added together. An organization’s expense estimate may already include payments to outside firms, depending on its reporting method.
Lobbying over time
| Year | In-house expenses | Outside-firm income |
|---|---|---|
| 2015 | $1.8M | $40K |
| 2016 | $1.6M | $110K |
| 2017 | $1.6M | $250K |
| 2018 | $2M | $360K |
| 2019 | $2.4M | $360K |
| 2020 | $2.7M | $360K |
| 2021 | $2.1M | $360K |
| 2022 | $2.2M | $350K |
| 2023 | $1.9M | $440K |
| 2024 | $3.3M | $660K |
| 2025 | $3.8M | $925K |
| 2026 | $1.7M | $570K |
What they lobbied on
Health Issues · 125Taxation/Internal Revenue Code · 68Medicare/Medicaid · 65Pharmacy · 62Defense · 10Trade (domestic/foreign) · 8Agriculture · 8
Outside lobbying firms
| Firm / registrant | Active filings | Reported income |
|---|---|---|
| TCH GROUP, LLC | 44 | $1.2M |
| HARBINGER STRATEGIES, LLC | 37 | $2.2M |
| BROWNSTEIN HYATT FARBER SCHRECK, LLP | 12 | $720K |
| INLET STRATEGIES | 10 | $280K |
| THE DUBERSTEIN GROUP INC. | 5 | $375K |
| MONUMENT ADVOCACY | 2 | $60K |
Only the latest filing in each registrant/client/quarter series contributes to these totals.
Lobbyists listed on disclosures
ADAM STEINMETZ
ALICE LUGO
Covered position: Assistant Secretary for Leg Affairs, Dept Homeland Security; Chief Counsel, Sen Menendez; Acting Leg Director, Sen Menendez; Counsel, Rep Luis Gutierrez; Legal Fellow, Rep Luis Gutierrez; Legal Fellow, Dep of Homeland Security; Intern, Sen Ben Nelson
ANDREW USYK
Covered position: Leg Assistant, Sen. Robert Casey; Legislative Aide, Sen. Kristen Gillibrand; Legislative Correspondent, Sen. Kristen Gillibrand; Compliance Officer, Sen. Gillibrand; Intern, Sen. Gillibrand and Rep. John Dingell
ASHLEY ROSE O'SULLIVAN
BENJAMIN R HOWARD
BRADFORD TALLAMY
BRIAN THOMAS MCGUIRE
Covered position: Asst Sec. for Legis. Affairs, Treasury; Counselor, Treasury; COS, Sen McConnell; Acting Staff Dir, R Comm Center, Sen McConnell; Dep Com Dir, Sen McConnell; Chief Speechwriter, Sen McConnell; Chief Speechwriter, HUD
COLTON HENNING
COREY AUSTIN MCGEE
DARRELL ROGERS
DAVID J SCHIAPPA
DEEMA TARAZI
DOUGLAS S WILEY
ELIZABETH KELLEY
EMILY FELDER
FREDERICK ESSIS
GREGORY SUNSTRUM
JASON R. MONEY
JOEL WHITE
JOHN HOLSCLAW
Covered position: Senate floor staff, Republican Secretary's office
Covered position: Senate Floor staff, Republican Secretary's Office
JOHN J O'NEILL jr
Covered position: Policy Director/Counsel, Senate Minority Whip 04-06; Tax Counsel, Senate Finance Committee 07
JOHN LEGANSKI
Covered position: Chief Dep., Speaker Off. '23; Chief Dep., Min. Leader Off. '22; Floor Dir., Min. Leader Off. '19-'21; Floor Dir., Maj. Leader Off. '17-'19; Dep. Floor Dir., Maj. Leader Off. '16; Floor Assist. Maj. Leader Off. '14-'15; Floor Assist. Maj. Whip Off.'1
JONATHAN SLEMROD
Covered position: Associate Director, Legislative Affairs, Office of Management and Budget, '17-'18, Policy Advisor, Office of the Sen. Republican Whip, '12-'17, Legislative Assistant, Sen. Marco Rubio '11-'12
Covered position: Associate Director, Legislative Affairs, Office of Management and Budget, '17-'18, Policy Advisor, Office of the Sen. Republican Whip, '12-'17, Legislative Assistant, Sen. Marco Rubio '11-'12.
Covered position: *IMPORTANT NOTE: Only participates in lobbying Senate and House. Does not lobby any Administration.
Covered position: Legislative Assistant, Sen. Marco Rubio '11-'12, Legislative Correspondent, Congressman Paul Ryan '10-'11; Staff Assistant, Congressman Jeff Flake,'10 *IMPORTANT NOTE: Only participates in lobbying Senate and House. Does not lobby any Administration.
JONATHAN TOWERS
Covered position: Staff Dir, Senate Vet Affairs, GOP Staff; Staff Dir, House Vet Affairs, GOP; Dep. Staff Dir, House Vet Affairs, GOP; Sr Health Policy Advisor, Senate Vet Affairs, GOP; Sr Prof Staff Mem. Senate Vet Affairs, GOP; Prof Staff Mem Senate Vet Affairs, GOP
KATHERINE WINKLER KEATING
KYLE NEVINS
Covered position: Deputy Chief of Staff, House Majority Leader 11-13; Floor Director, Rep. Eric Cantor 09-10; Floor Director, Rep. Roy Blunt 07-08; Floor Assistant, Rep. Roy Blunt 03-06
Covered position: Deputy Chief of Staff, House Majority Leader 11-13; Floor Director, Rep. Eric Cantor 09-10; Floor Director, Rep. Roy Blunt 07-08; Floor Assistant, Rep. Roy Blunt 03-06.
LAUREN ALEXANDRA MISH
Covered position: Intern, Rep. Brian Fitzpatrick (PA-01); Intern, Department of Health and Human Services in the Office of Global Affairs
MANNY ROSSMAN
Covered position: Chief of Staff, Office of the Senate Republican Whip 07-09; Senior Policy Advisor, Office of Sen. Trent Lott 05-06; Legislative Director, Rep. Phil Crane 03-04; Legislative Assistant, Rep. Phil Crane 01-02
Covered position: Legislative Assistant, Rep. Phil Crane 01-02, Legislative Director, Rep. Phil Crane 03-04, Senior Policy Advisor, Office of Sen. Trent Lott 05-06, Chief of Staff, Office of the Senate Republican Whip 07-09.
Covered position: Legislative Assistant, Rep. Phil Crane 01-02, Legislative Director, Rep. Phil Crane 03-04, Senior Policy Advisor, Office of Sen. Trent Lott 05-06, Chief of Staff, Office of the Senate Republican Whip 07-09
MICHAEL TONGOUR
PARKER H. POLING
Covered position: Spec. Asst to Dir. of Media Affairs 01-03; Comm. on Educ. and Workforce, Chairman Boehner 03-04; Law Clerk to Chairman Toner, FEC 05-06; COS, Cong. McHenry 07-14; COS, Chief Dep. Whip McHenry 14-18 in Office of Maj. Whip Scalise.
RITA E NORTON
SHELLY MUI-LIPNIK
STEVE STOMBRES
Covered position: Chief of Staff, Office of the Majority Leader 10-14; Chief of Staff, Office of the Minority Whip 08-09; Chief of Staff, Office of the Chief DeputyMajorityWhip04-07; Chief of Staff, Congressman Eric Cantor 01-03
Covered position: Chief of Staff, Office of the Majority Leader 10-14; Chief of Staff, Office of the Minority Whip 08-09; Chief of Staff, Office of the Chief Deputy Majority Whip04-07; Chief of Staff, Congressman Eric Cantor 01-03.
THOMAS WHARTON
Covered position: Health Legislative Assistant - Senator Joe Lieberman. May 2011-June 2012: Senior Legislative Assistant - Congressman Dan Boren July 2008-June 2011
VIVIENNE STAFFORD MITCHELL
Covered position: Staff Assistant, U.S. Senator Elizabeth Dole (2008)
WILLIAM DUNHAM
Covered position: Dep CoS Policy-Ldr Kevin McCarthy; Policy Dir-McCarthy; Exec Dir-R Study Comm; Sr Policy Advisor-R Study Comm; Sr Leg. Asst-Rep Tom McClintock; Leg Asst-Rep Tom McClintock; Leg Cor-Rep Tom McClintock
ZACHARY PFISTER
Filing-level audit trail
Superseded filings remain visible for auditability but are excluded from every total above.
2nd Quarter (Apr 1 - June 30) 2026 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- ee689e50-c136-4c38-bc39-183c16c9cc8f
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 21, 2026
Defense
The FY2027 National Defense Authorization Act (H.R.8800/S.4784): issues related to DoDs supply of essential and lifesaving medicines.
Health Issues
Issues related to Healthcare Reform.
Taxation/Internal Revenue Code
The FY2027 Budget Resolution (H.Con.Res 113): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues.
2nd Quarter (Apr 1 - June 30) 2026 · CENCORA, INC. · $510K · Active
- Filing ID
- 93be79b4-aac0-4292-abde-895184a3f527
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Jul 20, 2026
Medicare/Medicaid
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortage Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicares Part B Physician Fee Schedule CMS ASP Certification Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule Distributor bona fide service fees
Trade (domestic/foreign)
Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act
Health Issues
Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act (NDAA - H.R.8800) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS FY 2026 Medicares Part B Physician Fee Schedule Rule CMS ASP Certification Break Up Big Medicine Act (S. 3822) Management Services Organization (MSO) Role and value of community specialty physicians and MSOs Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)
Taxation/Internal Revenue Code
Global Intangible Low-taxed Income (GILTI) Territorial Economic Recovery Act (H.R. 363) The Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act (H.R. 3042) Restore Economic Vitality and Investment in the Virgin Islands Act (REVIVE VI Act) (858)
Pharmacy
Preventing and mitigating generic drug shortages Ensuring Seniors Access to Critical Medications Act/ Main Street Pharmacy Access Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement
2nd Quarter (Apr 1 - June 30) 2026 · THE DUBERSTEIN GROUP INC. · $75K · Active
- Filing ID
- 33818bd1-da4d-4cc2-85e0-aee9959be1d8
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- THE DUBERSTEIN GROUP INC.
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2026
Health Issues
Issues related to health care and pharmaceutical industry
Trade (domestic/foreign)
Issues related to trade
2nd Quarter (Apr 1 - June 30) 2026 · INLET STRATEGIES · $30K · Active
- Filing ID
- 68e1ecaf-c78c-4985-963d-b342da29a4bc
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2026
Health Issues
Issues related to drug shortages and the medical supply chain. Issues related to the federal tax rate of corporations and their inventory. Issues related to health care consolidation and business acquisitions.
Taxation/Internal Revenue Code
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico
Medicare/Medicaid
Issues related to drug shortages and the medical supply chain Issues related to the federal tax rate of corporations and their inventory Issues related to health care consolidation and acquisitions.
2nd Quarter (Apr 1 - June 30) 2026 · MONUMENT ADVOCACY · $30K · Active
- Filing ID
- d6ad24df-cc9d-4151-b1d7-2e755060dfc9
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- MONUMENT ADVOCACY
- Client
- CENCORA
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2026
Health Issues
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
2nd Quarter (Apr 1 - June 30) 2026 · TCH GROUP, LLC · $30K · Active
- Filing ID
- 3924770a-d917-4976-9153-ff1d895dfd17
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 16, 2026
Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)
2nd Quarter (Apr 1 - June 30) 2026 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- fac61e73-e378-4ccd-afa6-c83e1312485b
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 16, 2026
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
Health Issues
Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
1st Quarter (Jan 1 - Mar 31) 2026 · CENCORA, INC. · $1.2M · Active
- Filing ID
- 61f1f5cb-cc95-4d27-924d-b039ff24d862
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Apr 21, 2026
Taxation/Internal Revenue Code
Global Intangible Low-taxed Income (GILTI) Territorial Economic Recovery Act (H.R. 363) The Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act (H.R. 3042) Restore Economic Vitality and Investment in the Virgin Islands Act (REVIVE VI Act) (858)
Medicare/Medicaid
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under CMS FY 2026 Medicare's Part B physician fee schedule. Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Preventing and Mitigating Generic Drug Shortages CMS FY 2026 Medicares Part B Physician Fee Schedule: Proposed Changes to Bonafide Service Fees
Health Issues
Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act FY2026 (NDAA) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS Medicare Part B Physician Fee Schedule Rule Break Up Big Medicine Act (S. 3822) CMS FY 2026 Medicares Part B Physician Fee Schedule: Proposed Changes to Bonafide Service Fees Role and value of community specialty physicians and MSOs
Pharmacy
Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement
Trade (domestic/foreign)
Tariff proposed policies
1st Quarter (Jan 1 - Mar 31) 2026 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- 1df52fc5-1b22-420e-b83c-cc915d3ca21f
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2026
Taxation/Internal Revenue Code
The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues.
Health Issues
Issues related to Healthcare Reform.
Defense
The FY2027 National Defense Authorization Act (No Bill Number): issues related to DoDs supply of essential and lifesaving medicines.
1st Quarter (Jan 1 - Mar 31) 2026 · MONUMENT ADVOCACY · $30K · Active
- Filing ID
- 8628ce76-c486-4866-bd32-a82be436c9ee
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- MONUMENT ADVOCACY
- Client
- CENCORA
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2026
Health Issues
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
1st Quarter (Jan 1 - Mar 31) 2026 · THE DUBERSTEIN GROUP INC. · $75K · Active
- Filing ID
- a9f7d84e-9846-4733-87c1-8a8dcaa98179
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- THE DUBERSTEIN GROUP INC.
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2026
Trade (domestic/foreign)
Issues related to trade
Health Issues
Issues related to health care and pharmaceutical industry
1st Quarter (Jan 1 - Mar 31) 2026 · INLET STRATEGIES · $30K · Active
- Filing ID
- 72133429-fdf6-4dd1-83cf-d2a6ffc6c53b
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 19, 2026
Taxation/Internal Revenue Code
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico
Medicare/Medicaid
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Health Issues
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
1st Quarter (Jan 1 - Mar 31) 2026 · TCH GROUP, LLC · $30K · Active
- Filing ID
- d6d21f05-cbf5-4c12-b0e0-1534f65bbe2c
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 16, 2026
Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)
1st Quarter (Jan 1 - Mar 31) 2026 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- 5af40bc7-000b-4b9e-90fb-6276bfdd2b05
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 15, 2026
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
4th Quarter (Oct 1 - Dec 31) 2025 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- c0fb0260-d9c0-44e1-b8bf-5473e8702fb7
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 21, 2026
Defense
The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines.
Taxation/Internal Revenue Code
The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues.
Health Issues
Issues related to Healthcare Reform.
4th Quarter (Oct 1 - Dec 31) 2025 · CENCORA, INC. · $1.9M · Active
- Filing ID
- 429d2b31-9d92-4b90-979c-97d282389a2a
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Jan 20, 2026
Medicare/Medicaid
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R.4299) Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages CMS Proposed Medicare Physician Fee Schedule Rule Proposed Changes to Bonafide Service Fees
Pharmacy
Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)
Taxation/Internal Revenue Code
Global Intangible Low-taxed Income (GILTI) Last in First Out (LIFO) accounting method
Trade (domestic/foreign)
Tariff proposed policies
Health Issues
Strategic National Stockpile Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483/S.2121) Medical Supply Resiliency Act (H.R. 2231) National Defense Authorization Act FY2026 (NDAA) Supply Chain Resiliency Most Favored Nation drug pricing proposals CMS Proposed Medicare Physician Fee Schedule Rule
4th Quarter (Oct 1 - Dec 31) 2025 · THE DUBERSTEIN GROUP INC. · $75K · Active
- Filing ID
- f26fb89d-3ddc-4dc1-a63e-ab79fd1b5fc2
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- THE DUBERSTEIN GROUP INC.
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 19, 2026
Health Issues
Issues related to health care and pharmaceutical industry
Trade (domestic/foreign)
Issues related to trade Introductions & issues related to supply chains
4th Quarter (Oct 1 - Dec 31) 2025 · INLET STRATEGIES · $30K · Active
- Filing ID
- bd1251d6-20fb-4a08-b12d-604c436dbe1d
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 19, 2026
Health Issues
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Medicare/Medicaid
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Taxation/Internal Revenue Code
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico
4th Quarter (Oct 1 - Dec 31) 2025 · TCH GROUP, LLC · $30K · Active
- Filing ID
- b3e7fb9b-c08f-48b7-afee-a502c9df8cbc
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 16, 2026
Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)
4th Quarter (Oct 1 - Dec 31) 2025 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- f7e890ef-ec07-42e5-ab37-79b907e2c8f1
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 15, 2026
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
3rd Quarter (July 1 - Sep 30) 2025 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- b167220d-58eb-4505-8053-f0df14579143
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 21, 2025
Defense
The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines.
Taxation/Internal Revenue Code
The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues.
Health Issues
Issues related to Healthcare Reform.
3rd Quarter (July 1 - Sep 30) 2025 · CENCORA, INC. · $680K · Active
- Filing ID
- 9abd8d0a-4959-4deb-8a8c-92a5fa0d4915
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Oct 20, 2025
Taxation/Internal Revenue Code
One Big Beautiful Bill Act/Budget Reconciliation (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI)
Health Issues
Strategic National Stockpile. Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483/S.2121) Medical Supply Resiliency Act National Defense Authorization Act FY2026 (NDAA) Supply Chain Resiliency Most Favored Nation drug pricing proposals One Big Beautiful Bill Act / Budget Reconciliation (H.R.1) CMS Proposed Medicare Physician Fee Schedule Rule
Pharmacy
Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)
Medicare/Medicaid
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). CMS Proposed Medicare Physician Fee Schedule Rule Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages
3rd Quarter (July 1 - Sep 30) 2025 · THE DUBERSTEIN GROUP INC. · $75K · Active
- Filing ID
- 693d2d50-07ff-4fe0-a727-57f357ea82f8
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- THE DUBERSTEIN GROUP INC.
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 20, 2025
Trade (domestic/foreign)
Issues related to trade
Health Issues
Issues related to health care and pharmaceutical industry
3rd Quarter (July 1 - Sep 30) 2025 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- 4d155fcf-46bf-448e-b670-9e317cc85b23
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 16, 2025
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
3rd Quarter (July 1 - Sep 30) 2025 · TCH GROUP, LLC · $30K · Active
- Filing ID
- 22fb03cc-72b9-4977-9c31-7ebf214d0868
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 16, 2025
Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, pharmacists' services, and proposals regarding bona fide service fees (2026 Physician Fee Schedule)
3rd Quarter (July 1 - Sep 30) 2025 · INLET STRATEGIES · $30K · Active
- Filing ID
- 86d647d3-1ab5-4a51-a57c-53f64aa30d77
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 13, 2025
Health Issues
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Taxation/Internal Revenue Code
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands
Medicare/Medicaid
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
2nd Quarter (Apr 1 - June 30) 2025 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- 9526ed9b-d48d-4c3d-9bf6-756ac1320076
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 22, 2025
Health Issues
Issues related to Healthcare Reform.
Taxation/Internal Revenue Code
The One Big Beautiful Bill Act (H.R.1): issues related to the tax treatment of the LIFO inventory valuation method and business tax issues.
Defense
The FY2026 National Defense Authorization Act (H.R.3838/S.2296): issues related to DoDs supply of essential and lifesaving medicines.
2nd Quarter (Apr 1 - June 30) 2025 · CENCORA, INC. · $760K · Active
- Filing ID
- 4e579df0-21ef-4ddc-a772-0c581266b654
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Jul 21, 2025
Pharmacy
Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164) Impacts to pharmacy Part D drug pricing in IRA
Health Issues
Strategic National Stockpile. Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT Act Reauthorization Medical Supply Resiliency Act National Defense Authorization Act (NDAA) Supply Chain Resiliency Budget Reconciliation Most Favored Nation drug pricing proposals
Medicare/Medicaid
Ensuring Community Access to Pharmacist Services Act (H.R. 3164) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages
Taxation/Internal Revenue Code
One Big Beautiful Bill Act (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI)
2nd Quarter (Apr 1 - June 30) 2025 · THE DUBERSTEIN GROUP INC. · $75K · Active
- Filing ID
- 81e4dd70-e6af-46a9-802c-8afa04b3d816
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- THE DUBERSTEIN GROUP INC.
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 21, 2025
Trade (domestic/foreign)
Issues related to trade
2nd Quarter (Apr 1 - June 30) 2025 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- d57ed91c-39e4-489a-af8e-6917fdf0e651
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 16, 2025
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
2nd Quarter (Apr 1 - June 30) 2025 · INLET STRATEGIES · $30K · Active
- Filing ID
- 7a6be16b-27c2-450e-b4ee-b3132571b69d
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 14, 2025
Medicare/Medicaid
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Taxation/Internal Revenue Code
HR 1: The One Big Beautiful Bill Act Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands
Health Issues
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
2nd Quarter (Apr 1 - June 30) 2025 · TCH GROUP, LLC · $20K · Active
- Filing ID
- 91c58077-eba8-4694-90c3-1f5fc857adec
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 14, 2025
Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, and pharmacists' services
1st Quarter (Jan 1 - Mar 31) 2025 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- 3b0e4524-d673-435f-9eca-ab0d9b545dff
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 22, 2025
Health Issues
Issues related to Healthcare Reform.
Defense
The FY2026 National Defense Authorization Act (No Bill Number): issues related to DoDs supply of essential and lifesaving medicines.
Taxation/Internal Revenue Code
Tax reconciliation legislation (No Bill Number): issues related to the tax treatment of the LIFO inventory valuation method. General monitoring of business tax issues.
1st Quarter (Jan 1 - Mar 31) 2025 · CENCORA, INC. · $450K · Active
- Filing ID
- c5f1f6f9-30a9-4162-b3b4-f21269b6d576
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Apr 21, 2025
Taxation/Internal Revenue Code
Tax Cuts and Jobs Act of 2017. LIFO accounting method Global Intangible Low-taxed Income (GILTI) Fiscal Year 2025 Budget Resolution (S. CON. RES. 7/ H.Con.Res.14)
Health Issues
Strategic National Stockpile. Essential Medicines Strategic Stockpile Act Prescription Information Modernization Act Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT Act Reauthorization FY2025 National Defense Authorization Act (NDAA) Seniors Access to Critical Medications Act (H.R. 2484) Department of Defense Essential Medicines Strategic Stockpile Amendment to NDAA
Pharmacy
Pharmacy and Medically Underserved Area Enhancement Act Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act Seniors Access to Critical Medications Act (H.R. 2484)
Medicare/Medicaid
The Equitable Community Access to Pharmacist Services Act Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act Seniors Access to Critical Medicines Act (H.R. 2484) Protecting Patient Access to Cancer and Complex Therapies Act Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages
1st Quarter (Jan 1 - Mar 31) 2025 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- 8adabcad-ca56-4d0f-8ebe-dfc21da16c81
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 18, 2025
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
1st Quarter (Jan 1 - Mar 31) 2025 · TCH GROUP, LLC · $20K · Active
- Filing ID
- 0fb7d1e3-4733-4b1e-8ad5-27d42b5253f2
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 17, 2025
Health Issues
Issues related to the pharmaceutical supply chain, drug shortages, drug pricing, national stockpiles, and pharmacists' services
1st Quarter (Jan 1 - Mar 31) 2025 · INLET STRATEGIES · $30K · Active
- Filing ID
- be7f34d5-1b8e-460c-bc9d-4b983a111aef
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 14, 2025
Health Issues
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Medicare/Medicaid
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
4th Quarter (Oct 1 - Dec 31) 2024 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- 2ab00d94-d37d-46fb-ba2a-a0ea08442c6a
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 21, 2025
Defense
The FY2025 National Defense Authorization Act (H.R. 8070): issues related to DoDs supply of essential and lifesaving medicines.
Taxation/Internal Revenue Code
General monitoring of business tax issues.
Health Issues
Issues related to Healthcare Reform.
4th Quarter (Oct 1 - Dec 31) 2024 · CENCORA, INC. · $1.1M · Active
- Filing ID
- 59a66007-3081-42e7-8023-c89b24285fe8
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Jan 21, 2025
Medicare/Medicaid
Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477) Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Senate Finance Draft Medicare Drug Shortage Prevention Policies
Taxation/Internal Revenue Code
Tax Cuts and Jobs Act of 2017. LIFO accounting method
Health Issues
Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S.2510/H.R.6802). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY2025 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution. Seniors Access to Critical Medications Act of 2023 (H.R. 5526/S.3458) Department of Defense Essential Medicines Strategic Stockpile Amendment to NDAA Health Care Cybersecurity Improvement Act of 2024 (S.4054) Broadening Utilization of Proven and Effective Treatment for Recovery Act or the BUPE for Recovery Act (H.R.9886/S.5271)
Pharmacy
Pharmacy and Medically Underserved Area Enhancement Act (S.1491). Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477). Seniors Access to Critical Medications Act of 2023 (H.R. 5526/S.3458) House and Senate Agriculture, FDA and related agency Appropriation bills House and Senate Labor/HHS Appropriations bills
4th Quarter (Oct 1 - Dec 31) 2024 · TCH GROUP, LLC · $20K · Active
- Filing ID
- b0e9c37d-6fbe-4bfd-a2ec-672e915fdac2
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 17, 2025
Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113
4th Quarter (Oct 1 - Dec 31) 2024 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- 31027d86-832e-423c-b89e-340e3f181f62
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 16, 2025
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
4th Quarter (Oct 1 - Dec 31) 2024 · INLET STRATEGIES · $30K · Active
- Filing ID
- c4af9393-7586-466b-bfe7-49b61db59aae
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 2, 2025
Medicare/Medicaid
Drug shortage policy and issues related to drug shortages and the medical supply chain S.2973-Modernizing and Ensuring PBM Accountability Act
Health Issues
Drug shortage policy and issues related to drug shortages and the medical supply chain. S.2973-Modernizing and Ensuring PBM Accountability Act
3rd Quarter (July 1 - Sep 30) 2024 · CENCORA, INC. · $570K · Active
- Filing ID
- 7210d474-3a60-4ffb-8968-a8a93f1636d7
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Oct 21, 2024
Taxation/Internal Revenue Code
Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate. H.R. 4355/S.2829 the Rural Veterinary Workforce Act.
Pharmacy
Pharmacy and Medically Underserved Area Enhancement Act (S.1491). House and Senate Agriculture, FDA, and related agency Appropriations bills. House and Senate Labor/HHS appropriations bills. Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477). Seniors Access to Critical Medications Act of 2023 (H.R. 5526/S.3458)
Health Issues
Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Ensuring essential medication supply for military and Department of Defense. Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S.2510/H.R.6802). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY2025 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution. Seniors Access to Critical Medications Act of 2023 (H.R. 5526/S.3458) Department of Defense Essential Medicines Strategic Stockpile Amendment to NDAA Health Care Cybersecurity Improvement Act of 2024 (S.4054) Drug Supply Chain Security Act (DSCSA)
Medicare/Medicaid
Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Senate Finance Draft Medicare Drug Shortage Prevention Policies
3rd Quarter (July 1 - Sep 30) 2024 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- 6b0853a7-4dc1-47cd-aedb-fa58468ac1a1
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 21, 2024
Taxation/Internal Revenue Code
General monitoring of business tax issues.
Health Issues
Issues related to Healthcare Reform.
Defense
The FY2025 National Defense Authorization Act (H.R. 8070): issues related to DoDs supply of essential and lifesaving medicines.
3rd Quarter (July 1 - Sep 30) 2024 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- ede8fc33-1c42-41eb-9a3a-0da0528b57c1
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 18, 2024
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
3rd Quarter (July 1 - Sep 30) 2024 · INLET STRATEGIES · $30K · Active
- Filing ID
- 09e60bb3-f2cf-47f3-b05e-8fff5c3e5ae7
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 16, 2024
Health Issues
Drug shortage policy and issues related to drug shortages and the medical supply chain. S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Medicare/Medicaid
Drug shortage policy and issues related to drug shortages and the medical supply chain S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
3rd Quarter (July 1 - Sep 30) 2024 · TCH GROUP, LLC · $20K · Active
- Filing ID
- e0479a5f-1ac3-46dd-9ecf-c49413dccb36
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Oct 10, 2024
Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113
2nd Quarter (Apr 1 - June 30) 2024 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- 90c3721c-f8c9-4e7f-baf7-074ba041740d
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 22, 2024
Defense
The FY2025 National Defense Authorization Act (H.R. 8070): issues related to DoDs supply of essential and lifesaving medicines.
Taxation/Internal Revenue Code
General monitoring of business tax issues.
Health Issues
Issues related to Healthcare Reform.
2nd Quarter (Apr 1 - June 30) 2024 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- 072a3be9-6257-4fdd-9281-7e83b78a4347
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 22, 2024
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
2nd Quarter (Apr 1 - June 30) 2024 · CENCORA, INC. · $440K · Active
- Filing ID
- fe3c2e5e-f793-44d9-b0ff-84558ba0ef97
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Jul 22, 2024
Taxation/Internal Revenue Code
Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate. H.R. 4355/S.2829 the Rural Veterinary Workforce Act.
Health Issues
Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Ensuring essential medication supply for military and Department of Defense. Digital communication of prescribing information. Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S.2510/H.R.6802). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY2025 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution. Seniors Access to Critical Medications Act of 2023 (H.R. 5526) Department of Defense Essential Medicines Strategic Stockpile Amendment to NDAA Health Care Cybersecurity Improvement Act of 2024 (S.4054)
Pharmacy
Pharmacy and Medically Underserved Area Enhancement Act (S.1491). House and Senate Agriculture, FDA, and related agency Appropriations bills. House and Senate Labor/HHS appropriations bills. Preventing and Mitigating Generic Drug Shortages: Policy Options The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477). Seniors Access to Critical Medications Act of 2023 (H.R. 5526)
Medicare/Medicaid
Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Inflation Reduction Act. Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages. Part B drug pricing changes. Enhanced Oncology Model (EOM). Preventing and Mitigating Generic Drug Shortages: Policy Options Senate Finance Draft Medicare Drug Shortage Prevention Policies Medicaid Stacking Issues
2nd Quarter (Apr 1 - June 30) 2024 · TCH GROUP, LLC · $20K · Active
- Filing ID
- ff263cb9-25fb-47ce-94dc-befaf249f4f4
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 13, 2024
Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113 Issues pertaining to Health sector cybersecurity
2nd Quarter (Apr 1 - June 30) 2024 · INLET STRATEGIES · $30K · Active
- Filing ID
- 7e82e2eb-f101-4e96-804d-9b445a3f5961
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jul 7, 2024
Health Issues
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Medicare/Medicaid
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
1st Quarter (Jan 1 - Mar 31) 2024 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- baec8a50-b76d-414f-96eb-092f0e71a1dd
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 23, 2024
Taxation/Internal Revenue Code
Business tax issues.
Health Issues
Issues related to Healthcare Reform.
Defense
The FY2025 National Defense Authorization Act (no bill number): Issues related to DoDs supply of essential and lifesaving medicines.
1st Quarter (Jan 1 - Mar 31) 2024 · CENCORA, INC. · $1.2M · Active
- Filing ID
- 2d947ba1-acd1-4a4a-97ec-11eb4e9fea01
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Apr 22, 2024
Taxation/Internal Revenue Code
Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate.
Pharmacy
Pharmacy and Medically Underserved Area Enhancement Act (S.1491). House and Senate Agriculture, FDA, and related agency Appropriations bills. House and Senate Labor/HHS appropriations bills. Prescription drug importation. Preventing and Mitigating Generic Drug Shortages: Policy Options The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477).
Health Issues
Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Ensuring essential medication supply for military and Department of Defense. Digital communication of prescribing information. Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages. Block, Report and Suspend Suspicious Shipments Act (H.R.501). Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S.2510/H.R.6802). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY2024 National Defense Authorization Act. FY2025 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution.
Medicare/Medicaid
Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Inflation Reduction Act. Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages. Part B drug pricing changes. Enhanced Oncology Model (EOM). Preventing and Mitigating Generic Drug Shortages: Policy Options Senate Finance Draft Medicare Drug Shortage Prevention Policies Medicaid Stacking Issues
1st Quarter (Jan 1 - Mar 31) 2024 · TCH GROUP, LLC · $20K · Active
- Filing ID
- c2467ffa-3ab8-4cc7-8fc9-f99370361db3
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TCH GROUP, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 19, 2024
Health Issues
Issues pertaining to pharmacists' services including HR 1770 and S 2477, Equitable Community Access to Pharmacists Services and S.1491 Pharmacy and Medically Underserved Areas Enhancement Act Issues relating to the pharmaceutical supply chain, including HR 405, Essential Medicines Strategic Stockpile Act Drug pricing legislation, including S 113 Issues pertaining to Health sector cybersecurity
1st Quarter (Jan 1 - Mar 31) 2024 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- 391d599e-9288-41ec-9123-491a93f51c79
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 18, 2024
Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
1st Quarter (Jan 1 - Mar 31) 2024 · INLET STRATEGIES · $10K · Active
- Filing ID
- 16a458d3-88f0-4c32-9b3b-c0682681dc4d
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- INLET STRATEGIES
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Apr 8, 2024
Health Issues
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act
Medicare/Medicaid
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act
4th Quarter (Oct 1 - Dec 31) 2023 · HARBINGER STRATEGIES, LLC · $60K · Active
- Filing ID
- 100b5a62-d145-428f-a20a-de6308b219b9
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- HARBINGER STRATEGIES, LLC
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 22, 2024
Taxation/Internal Revenue Code
Business tax issues.
Health Issues
Issues related to Healthcare Reform.
4th Quarter (Oct 1 - Dec 31) 2023 · CENCORA, INC. · $510K · Active
- Filing ID
- b22dc278-9ede-4b74-a8ba-dca7196b86e2
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- CENCORA, INC.
- Client
- CENCORA, INC.
- Amount classification
- In-house expenses · Method A
- Filed
- Jan 22, 2024
Pharmacy
Legislation to provide for coverage under Medicare program for pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act (S.1491). House and Senate Agriculture, FDA, and related agency Appropriations bills. House and Senate Labor/HHS appropriations bills. Prescription drug importation. Issues and policies related to generic drug shortages. The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477).
Health Issues
Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Ensuring essential medication supply for military and Department of Defense. Digital communication of prescribing information. Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages. Block, Report and Suspend Suspicious Shipments Act (H.R.501). Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S. 2510). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY 2024 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution.
Taxation/Internal Revenue Code
Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate.
Medicare/Medicaid
Medicare Part B Reimbursement. Average Sales Price (ASP). Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Inflation Reduction Act. Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages. Part B drug pricing changes. Enhanced Oncology Model (EOM).
4th Quarter (Oct 1 - Dec 31) 2023 · BROWNSTEIN HYATT FARBER SCHRECK, LLP · $60K · Active
- Filing ID
- 44fab9a4-f48b-4999-b808-8d71ebb5ef54
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- CENCORA, INC.
- Amount classification
- Outside-firm income
- Filed
- Jan 19, 2024
Pharmacy
Recognizing pharmacists as providers within Medicare, IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477), Medicare reimbursement.
Health Issues
Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
Source: U.S. House and Senate Lobbying Disclosure Act database / LDA.gov. Data last retrieved Aug 25, 2026. The Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Document library
Important Documents
Selected filings, reports, contracts, court records, and other documents useful for understanding this organization.
SEC Exhibit 21Company filing
Cencora Exhibit 21 — Subsidiaries
Cencora · Nov 25, 2025
Company-filed list of significant subsidiaries. The filing may omit subsidiaries that are not considered significant under SEC rules.
Documentation
Sources
- Original source ↗
Federal data refreshed September 22, 2026.
For researchers
Cite this page
The Paper Trail Project. “Cencora.” Accessed September 24, 2026. https://www.papertrailproject.org/profiles/cencora
Record last updated 2026-09-22. Sources: Linked public records. Verify consequential claims against the linked original records.